摘要
用NDV和副流感病毒腹腔注射治疗小鼠H_(22)腹水瘤,效果比较明显。NDV治疗组存活率为40%,NDV治疗组与对照组相比死亡鼠存活时间延长1.7倍。副流感病毒治疗组存活率为45%,治疗组与对照组相比死亡鼠存活时间延长2倍。
Present report concerns the study on the treatment of H_(22) ascitic tumor in mice with NDV strain and parainfluenza virus strain. The virus was given 3 times after transplantation of H_(22) ascitic tumor cells. In H_(22) the survival rate after 2 months observation varied between 30%—50% and the death date had delayed 10.8 days than the control group averagely in NDA strain group. In H_(22) the survival rate after 2 months observation varied between 40%—50% and the death date had delayed 17.0 days than the control group averagely in parainfluenza virus group. The mechanism of virus therapy will be reported later.
关键词
肿瘤抗原性
病毒免疫疗法
virus immunotherapy
tumor antigenicity